HAS opinions and decisions
La fiche de bon usage du médicament intitulée « Bon usage des médicaments utilisés dans les formes très actives de sclérose en plaques récurrente », ci-jointe, est adoptée.
See also
Évaluation des médicaments
08/10/2019
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
GEZT8037KBKGZYcb
